A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 301
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : UCB
Long Form : urothelial carcinoma of the bladder
No. Year Title Co-occurring Abbreviation
2021 Catalog of prognostic tissue-based biomarkers in patients treated with neoadjuvant systemic therapy for urothelial carcinoma of the bladder: a systematic review. IHC, NAST, NGS, QT PCR
2021 Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the Bladder. UC, UTUC, UTUC
2021 DNA Repair Gene Polymorphisms and Susceptibility to Urothelial Carcinoma in a Southeastern European Population. SNPs
2021 Grainyhead-Like 3 Influences Migration and Invasion of Urothelial Carcinoma Cells. GRHL3
2021 Impact of preoperative plasma levels of interleukin 6 and interleukin 6 soluble receptor on disease outcomes after radical cystectomy for bladder cancer. CSS, DCA, IL-6, OS, RC, RFS
2021 Impact of the preoperative modified glasgow prognostic score on disease outcome after radical cystectomy for urothelial carcinoma of the bladder. AUC, DCA, mGPS, RC
2021 Incidence trends and survival prediction of urothelial cancer of the bladder: a population-based study. C-index, CSS, IDI, NRI, ROC
2021 Prognostic blood-based biomarkers in patients treated with neoadjuvant chemotherapy for urothelial carcinoma of the bladder: A systematic review. NAC, NLR, OS, pCR, PLR, PR
2021 Prognostic Impact of Preoperative Plasma Levels of Urokinase Plasminogen Activator Proteins on Disease Outcomes after Radical Cystectomy. RC, uPA
10  2021 Prognostic markers in pT3 bladder cancer: A study from the international bladder cancer tissue microarray project. FFR, IHC, OS, TMA
11  2021 Prognostic value of HPV DNA in Urothelial Carcinoma of the Bladder: A Preliminary Report of 2-Year Follow-up Results. HPV, PCR
12  2021 Promoter hypomethylation as potential confounder of Ras gene overexpression and their clinical significance in subsets of urothelial carcinoma of bladder. K-Ras, MIBC, MSP, N-Ras, NMIBC, RAS, RT-qPCR
13  2021 The Prognostic Value of Body Mass Index in Patients With Urothelial Carcinoma After Surgery: A Systematic Review and Meta-Analysis. BMI, CI, CSS, HR, OS, RFS, UC, UTUC
14  2021 The Role of Interleukin-1-Receptor-Antagonist in Bladder Cancer Cell Migration and Invasion. CI, IL-1, RTCA, T24-IL1RA
15  2021 The Value of Preoperative Plasma VEGF Levels in Urothelial Carcinoma of the Bladder Treated with Radical Cystectomy. C-index, CSS, DCA, OS, RC, RFS, VEGF
16  2021 ZHX3 promotes the progression of urothelial carcinoma of the bladder via repressing of RGS2 and is a novel substrate of TRIM21. Co-IP, MS, RGS2, TRIM21, ZHX3
17  2021 [Prognostic analysis of patients with T1 stage high grade of bladder urothelial carcinoma and glandular differentiation]. LVI
18  2020 A California Cancer Registry Analysis of Urothelial and Non-urothelial Bladder Cancer Subtypes: Epidemiology, Treatment, and Survival. ADC, CCR, DSS, HR, OS, SCC, SmCC
19  2020 Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma. CAF, FFPE, IHC, LNM, LVI, PNI
20  2020 Cationic amphiphilic drugs as potential anticancer therapy for bladder cancer. CADs
21  2020 Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating ∆NP63 by sponging miR-762. ceRNA, circRNAs, FISH
22  2020 Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma. CI, CSS, HR, NAC, OR, UTUC
23  2020 Copy number variations in primary tumor, serum and lymph node metastasis of bladder cancer patients treated with radical cystectomy. cfDNA, CNV, MLPA, RC
24  2020 Development and Validation of a Nomogram to Predict Lymph Node Metastasis in Patients With T1 High-Grade Urothelial Carcinoma of the Bladder. LN, LVI, MLR, RC
25  2020 Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study. C-index, CSS, DCA, IDI, NRI, RC, ROC, SEER
26  2020 Differential Expression and Clinicopathological Significance of HER2, Indoleamine 2,3-Dioxygenase and PD-L1 in Urothelial Carcinoma of the Bladder. DFS, HER2, ICs, IDO, PD-L1, pT, TCs
27  2020 Disabled Homolog 2 (DAB2) Protein in Tumor Microenvironment Correlates with Aggressive Phenotype in Human Urothelial Carcinoma of the Bladder. DAB2, EMT, siRNA
28  2020 Gender discrepancies in bladder cancer: potential explanations. RC
29  2020 GULP1 regulates the NRF2-KEAP1 signaling axis in urothelial carcinoma. ---
30  2020 Impact of preoperative serum albumin-globulin ratio on disease outcome after radical cystectomy for urothelial carcinoma of the bladder. AGR, CI, DCA, OR, pAGR, RC
31  2020 Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results. CR, DCR, FGFR1-3, ORR, PR, SD, UTUC
32  2020 Is It Safe to Offer Radical Cystectomy to Patients above 85 Years of Age? A Long-Term Follow-Up in a Single-Center Institution. RC
33  2020 Mutational analysis of Ras hotspots in patients with urothelial carcinoma of the bladder. PCR-RFLP
34  2020 Nucleobindin 2 expression is an independent prognostic factor for bladder cancer. NUCB2
35  2020 Overexpression of lncRNA TINCR is associated with high-grade, invasive, and recurring tumors, and facilitates proliferation in vitro and in vivo of urothelial carcinoma of the bladder. lncRNAs, qPCR, TINCR
36  2020 PD-1 topographically defines distinct T cell subpopulations in urothelial cell carcinoma of the bladder and predicts patient survival. ---
37  2020 Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. ---
38  2020 Synchronous and metachronous urothelial carcinoma of the upper urinary tract and the bladder: Are they clonally related? A systematic review. IVR, UTUC
39  2020 The association of cigarette smoking and pathological response to neoadjuvant platinum-based chemotherapy in patients undergoing treatment for urinary bladder cancer - A prospective European multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group. CI, IQR, NAC, OR, RC, YAU
40  2020 The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder. RNU, UTUC
41  2020 The Impact of Circulating Tumor Cells on Venous Thromboembolism and Cardiovascular Events in Bladder Cancer Patients Treated with Radical Cystectomy. CCI, CDC, CTC, CVE, RC, VTE
42  2020 Urine Lactoferrin as a Potential Biomarker Reflecting the Degree of Malignancy in Urothelial Carcinoma of the Bladder. LF, TINs
43  2019 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. m5C
44  2019 Androgen Receptor mRNA Expression in Urothelial Carcinoma of the Bladder: A Retrospective Analysis of Two Independent Cohorts. AR, MIBC, NMIBC
45  2019 Aristolochic Acid and Immunotherapy for Urothelial Carcinoma: Directions for unmet Needs. AA
46  2019 Differentiating Nonfunctional Paraganglioma of the Bladder from Urothelial Carcinoma of the Bladder: Pitfalls and Breakthroughs. NPB, NPB
47  2019 Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes? ---
48  2019 Elevated pre-existing lymphocytic infiltrates in tumour stroma predict poor prognosis in resectable urothelial carcinoma of the bladder. DSS, HR, OS, SLI
49  2019 Epithelial-to-mesenchymal transition: Event and core associates in bladder cancer. EMT, EMT-ATFs, MET
50  2019 HMGB1 expression in urothelial carcinoma of the bladder. IUC, NIPUC, TUR
51  2019 Is There any Association between Urothelial Carcinoma of the Bladder and Human Papillomavirus? A Case-Control Study. DNA, HPV, PCR
52  2019 Late Recurrence of Bladder Cancer following Radical Cystectomy: Characteristics and Outcomes. DSS, LR, RC
53  2019 Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC). CHEK2, CSS, IHC, NMIBC, PFS, RFS
54  2019 Microlocalization and clinical significance of stabilin-1+ macrophages in treatment-naïve patients with urothelial carcinoma of the bladder. OS, RFS
55  2019 Molecular Predictors of Complete Response Following Neoadjuvant Chemotherapy in Urothelial Carcinoma of the Bladder and Upper Tracts. NAC, RC
56  2019 Optimal Management of Upper Tract Urothelial Carcinoma: an Unmet Need. UTUC
57  2019 Overexpression of CEP72 Promotes Bladder Urothelial Carcinoma Cell Aggressiveness via Epigenetic CREB-Mediated Induction of SERPINE1. CEP, SERPINE1
58  2019 Prognostic Role of the Immunoscore for Patients with Urothelial Carcinoma of the Bladder Who Underwent Radical Cystectomy. RC
59  2019 Radical cystectomy for pT1 urothelial carcinoma of bladder not amenable to TURBT: Long-term results. HGO, LGO, LN, LVI, MIBC, RC, TUR
60  2019 Special Issue on Molecular Research Efforts in Urothelial Carcinoma: Summary of Included Topics. IJMS
61  2019 The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients. AJCC, CI, COBRA, CSS, RC
62  2019 The effect of age and comorbidities on early postoperative complications after radical cystectomy: A contemporary population-based analysis. MLoR, OR, OR, RC, RR
63  2019 The impact of variant histological differentiation on extranodal extension and survival in node positive bladder cancer treated with radical cystectomy. CI, ENE, HR, LN, RC
64  2019 The prognostic value of sarcopenia in patients with surgically treated urothelial carcinoma: A systematic review and meta-analysis. CI, HR, UC, UTUC
65  2019 Toward Automated In Vivo Bladder Tumor Stratification Using Confocal Laser Endomicroscopy. LSTM, pCLE, WLC
66  2019 Transcription factor Nrf2 induces the up-regulation of lncRNA TUG1 to promote progression and adriamycin resistance in urothelial carcinoma of the bladder. ADM, MMP, NF-E2, p-gp, TUG1
67  2019 Urinary expression of genes involved in DNA methylation and histone modification for diagnosis of bladder cancer in patients with asymptomatic microscopic haematuria. AMH, HDAC9, OR
68  2018 A Panel of MicroRNA Signature as a Tool for Predicting Survival of Patients with Urothelial Carcinoma of the Bladder. miRNA
69  2018 Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells. CSC
70  2018 CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer. CSC
71  2018 Commentary on "Detection and oncological effect of circulating tumor cells in patients with variant urothelial carcinoma histology treated with radical cystectomy." CTC, RC, RFS
72  2018 CSTF2-Induced Shortening of the RAC1 3'UTR Promotes the Pathogenesis of Urothelial Carcinoma of the Bladder. 3'UTR, CSTF2
73  2018 Decreased Invasion of Urothelial Carcinoma of the Bladder by Inhibition of Matrix-Metalloproteinase 7. MMPs, qRT-PCR, TEER, UROtsa
74  2018 Evaluation of the clinical value of hematological parameters in patients with urothelial carcinoma of the bladder. MLR, NLR, OR, PLR, RDW
75  2018 Expression of CD74 in bladder cancer and its suppression in association with cancer proliferation, invasion and angiogenesis in HT-1376 cells. MIBC, MIF, MVD, NMIBC
76  2018 Expression of pyruvate kinase M2 in human bladder cancer and its correlation with clinical parameters and prognosis. IHC, PCR, PKM2
77  2018 Flavagline analog FL3 induces cell cycle arrest in urothelial carcinoma cell of the bladder by inhibiting the Akt/PHB interaction to activate the GADD45α pathway. ---
78  2018 Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer. KLalpha, KLbeta, KLgamma, siRNA
79  2018 Grade progression in urothelial carcinoma can occur with high or low mutational homology: a first-step toward tumor-specific care in initial low-grade bladder cancer. HG, LG
80  2018 High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder. CD, OS, PFS, TAM
81  2018 Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis. TERT
82  2018 Increased H2S and its synthases in urothelial cell carcinoma of the bladder, and enhanced cisplatin-induced apoptosis following H2S inhibition in EJ cells. CBS, CSE, MPST
83  2018 Long Non-Coding RNA Cancer Susceptibility Candidate 2a (CASC2a) Is a Marker of Early Recurrence After Radical Cystectomy in Patients with Urothelial Carcinoma of the Bladder. CASC2a, CIS, FISH, lncRNA, LVI, qRT-PCR, RC, STSM
84  2018 Poor prognosis of bladder cancer patients with occult lymph node metastases treated with neoadjuvant chemotherapy. CI, HR, LN, NAC, RC/PLND
85  2018 Positive Correlation between Matrix Metalloproteinases and Epithelial-to-Mesenchymal Transition and its Association with Clinical Outcome in Bladder Cancer Patients. EMT, EMT-ATFs, IHC, MIBC, MMPs, NMIBC, RT-qPCR
86  2018 Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy. CSS, LVI, OS, RC, RFS, VEGFR-3
87  2018 PRMT5 Circular RNA Promotes Metastasis of Urothelial Carcinoma of the Bladder through Sponging miR-30c to Induce Epithelial-Mesenchymal Transition. circRNAs, EMT
88  2018 Prognostic value of nutritional indices and body composition parameters including sarcopenia in patients treated with radiotherapy for urothelial carcinoma of the bladder. IQR
89  2018 Programmed death ligand-1 is associated with tumor infiltrating lymphocytes and poorer survival in urothelial cell carcinoma of the bladder. PD-L1, TIL
90  2018 The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder. CTC, ctDNA
91  2018 The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer. CTCs, MRD
92  2018 The molecular limitations of biomarker research in bladder cancer. ---
93  2018 TRIM65 supports bladder urothelial carcinoma cell aggressiveness by promoting ANXA2 ubiquitination and degradation. TRIM
94  2018 Upregulation of long non-coding RNA HNF1A-AS1 is associated with poor prognosis in urothelial carcinoma of the bladder. lncRNAs
95  2018 [CT texture analysis in bladder carcinoma: histologic grade characterization]. CTTA, HGUC, LGUC, ROC, VOI
96  2017 Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. AC, IPTW, NAC, OS, RC
97  2017 Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder. CI, IPTW, OS, RC, TMT
98  2017 Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study. cfDNA, CNV, MLPA, RC
99  2017 Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy. CTC, HR, RC, RFS
100  2017 Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder. DGs, LVI, PEs, PS